Johns Hopkins ABX Guide
Lopinavir/ritonavir
INDICATIONS
FDA
FDA
- Treatment of HIV infection in combination with other antiretrovirals in adults and pediatric patients (14 days and older).
There's more to see -- the rest of this topic is available only to subscribers.
Last updated: January 11, 2025
Citation
, Kathryn Dzintars, Pharm.D., BCPS, and Paul G Auwaerter. "Lopinavir/ritonavir." Johns Hopkins ABX Guide, The Johns Hopkins University, 2025. Pediatrics Central, peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540322/all/Lopinavir_ritonavir.
K, Auwaerter PG. Lopinavir/ritonavir. Johns Hopkins ABX Guide. The Johns Hopkins University; 2025. https://peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540322/all/Lopinavir_ritonavir. Accessed January 17, 2025.
, K., & Auwaerter, P. G. (2025). Lopinavir/ritonavir. In Johns Hopkins ABX Guide. The Johns Hopkins University. https://peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540322/all/Lopinavir_ritonavir
K, Auwaerter PG. Lopinavir/ritonavir [Internet]. In: Johns Hopkins ABX Guide. The Johns Hopkins University; 2025. [cited 2025 January 17]. Available from: https://peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540322/all/Lopinavir_ritonavir.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Lopinavir/ritonavir
ID - 540322
A1 - ,Kathryn Dzintars, Pharm.D., BCPS,
AU - Auwaerter,Paul,M.D.
Y1 - 2025/01/11/
BT - Johns Hopkins ABX Guide
UR - https://peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540322/all/Lopinavir_ritonavir
PB - The Johns Hopkins University
DB - Pediatrics Central
DP - Unbound Medicine
ER -
